Genmab — Marts 2020
-
https://www.worldometers.info/coronavirus/#countries Italien og Tyskland ser slemme ud i dag.
-
-
Ser ud til det hele går i selvsving p.g.a corona. Eksempelvis ingen døde i Tyskland og under 0.5% i Korea indikere efter min mening der sikkert er mange rundt omkring der går under radaren og ikke regristreret så dødligheden er nok som en typisk influenza når man indregner mørketal som flere experter nu er begyndt at pointere
-
God morgen.
-
Upfront multidrug regimens prove beneficial in Myeloma. https://www.onclive.com/web-exclusives/upfront-multidrug-regimens-prove-beneficial-in-myeloma
-
-
Dr. Raje on the efficacy of Belantamab Mafodotin in Multiple Myeloma. https://www.onclive.com/onclive-tv/dr-raje-on-the-efficacy-of-belantamab-mafodotin-in-multiple-myeloma
-
Sutro har et BCMA ADC under udvikling i samarbejde med BMS (tidligere Celgene), hvor man forventer at bivirkningsprofilen vil være markant bedre end GSKs BCMA ADC, da man anvender site specific conjugation. Sutro´s to egne ADC´er i klinikken har indtil videre ikke vist occular toxicity. Forventningen er at stoffet skal kunne gives på community centers ! Blot en lille reklame for Sutro
-
Nu 1558..:-(
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind